Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE)

Stage III locally advanced non-small cell lung cancer (NSCLC) is a heterogeneous condition affecting about one-third of the overall patients (1). Usually, therapeutic approach consists of a combination of local therapy (radiotherapy) with systemic platinum-based doublet chemotherapy. However, the prognosis remains poor, with only a limited improvement in survival achieved over the past 10 years. Recently, it has been shown that durvalumab significantly prolonged progression-free and overall survival, as compared with placebo, among patients with unresectable stage III NSCLC after concurrent chemoradiotherapy (2 –3).

Source: Lung Cancer - August 1, 2020 Category: Cancer & Oncology Authors: Alessandro Marchioni, Dario Andrisani, Roberto Tonelli, Roberto Piro, Alessandro Andreani, Gaia Francesca Cappiello, Emmanuela Meschiari, Massimo Dominici, Mario Bavieri, Fausto Barbieri, Sofia Taddei, Eleonora Casalini, Francesco Falco, Filippo Gozzi, Gi Source Type: research